Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of Sotagliflozin Versus Placebo in Patients With Type 2 Diabetes Mellitus on Background of Metformin

ClinicalTrials.gov ID: NCT02926950

Public ClinicalTrials.gov record NCT02926950. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 10:02 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Sotagliflozin Added to Metformin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin

Study identification

NCT ID
NCT02926950
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Lexicon Pharmaceuticals
Industry
Enrollment
518 participants

Conditions and interventions

Interventions

  • Sotagliflozin (SAR439954) Drug
  • Placebo Drug
  • Metformin Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2016
Primary completion
Feb 25, 2019
Completion
Mar 21, 2019
Last update posted
May 10, 2021

2016 – 2019

United States locations

U.S. sites
67
U.S. states
20
U.S. cities
53
Facility City State ZIP Site status
Investigational Site Number 8402003 Birmingham Alabama 35205
Investigational Site Number 8402017 Birmingham Alabama 35294
Investigational Site Number 8402052 Phoenix Arizona 85018
Investigational Site Number 8402056 Canoga Park California 91303
Investigational Site Number 8402020 Escondido California 92025
Investigational Site Number 8402028 Gold River California 95670
Investigational Site Number 8402067 Greenbrae California 94904
Investigational Site Number 8402025 Huntington Park California 90255
Investigational Site Number 8402051 La Mirada California 90638
Investigational Site Number 8402042 Lemon Grove California 91945
Investigational Site Number 8402011 Lincoln California 95648
Investigational Site Number 8402014 Long Beach California 90807
Investigational Site Number 8402066 Long Beach California 90807
Investigational Site Number 8402029 Los Angeles California 90022
Investigational Site Number 8402041 Los Angeles California 90036
Investigational Site Number 8402001 Los Angeles California 90057
Investigational Site Number 8402043 San Diego California 92103
Investigational Site Number 8402031 San Ramon California 94582
Investigational Site Number 8402047 Tarzana California 91356
Investigational Site Number 8402009 Boynton Beach Florida 33472
Investigational Site Number 8402016 Daytona Beach Florida 32117
Investigational Site Number 8402006 Hialeah Florida 33012
Investigational Site Number 8402035 Hialeah Florida 33012
Investigational Site Number 8402044 Hialeah Florida 33012
Investigational Site Number 8402045 Jacksonville Florida 32256
Investigational Site Number 8402026 Miami Florida 33126
Investigational Site Number 8402036 Miami Florida 33143
Investigational Site Number 8402064 Miami Florida 33183
Investigational Site Number 8402007 Miami Florida 33185
Investigational Site Number 8402061 Miami Florida 33186
Investigational Site Number 8402060 Miami Beach Florida 33140-3608
Investigational Site Number 8402033 Opa-locka Florida 33054
Investigational Site Number 8402039 Orlando Florida 32825
Investigational Site Number 8402063 West Palm Beach Florida 33406-5854
Investigational Site Number 8402038 Winter Haven Florida 33880
Investigational Site Number 8402008 Macon Georgia 31210
Investigational Site Number 8402054 Chicago Illinois 60607
Investigational Site Number 8402069 Newton Iowa 50208
Investigational Site Number 8402022 West Des Moines Iowa 50265
Investigational Site Number 8402059 Lexington Kentucky 40503
Investigational Site Number 8402068 Baton Rouge Louisiana 70808-4124
Investigational Site Number 8402012 Metairie Louisiana 70006
Investigational Site Number 8402037 New Orleans Louisiana 70119-6302
Investigational Site Number 8402053 New Orleans Louisiana 70124
Investigational Site Number 8402021 Rockville Maryland 20852
Investigational Site Number 8402062 Omaha Nebraska 68114-3755
Investigational Site Number 8402005 Las Vegas Nevada 89148
Investigational Site Number 8402018 Greensboro North Carolina 27401
Investigational Site Number 8402002 Morehead City North Carolina 28557
Investigational Site Number 8402019 Oklahoma City Oklahoma 73104
Investigational Site Number 8402015 Eugene Oregon 97404-3233
Investigational Site Number 8402058 Lansdale Pennsylvania 19446-1002
Investigational Site Number 8402030 Dallas Texas 75230
Investigational Site Number 8402050 DeSoto Texas 75115
Investigational Site Number 8402010 Fort Worth Texas 76164
Investigational Site Number 8402040 Houston Texas 77008
Investigational Site Number 8402065 Houston Texas 77058
Investigational Site Number 8402057 Houston Texas 77079
Investigational Site Number 8402049 Magnolia Texas 77355
Investigational Site Number 8402046 Odessa Texas 79761
Investigational Site Number 8402013 San Antonio Texas 78218
Investigational Site Number 8402004 San Antonio Texas 78229
Investigational Site Number 8402023 Schertz Texas 78154
Investigational Site Number 8402027 Clinton Utah 84015
Investigational Site Number 8402032 Salt Lake City Utah 84107
Investigational Site Number 8402024 Virginia Beach Virginia 23454
Investigational Site Number 8402034 Seattle Washington 98105

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 26 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02926950, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 10, 2021 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02926950 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →